| Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis |
Assets and liabilities measured at fair value on a recurring basis as of June 30, 2026 and December 31, 2025 are summarized below: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value Measure on a Recurring Basis | | ($ in thousands) | | Total Fair Value | | Quoted Prices in Active Markets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Significant Unobservable Inputs (Level 3) | | June 30, 2026 | | | | | | | | | Assets: | | | | | | | | | | AFS debt securities: | | | | | | | | | | U.S. Government agencies or sponsored agency securities: | | | | | | | | | | Residential mortgage-backed securities | | $ | 34,422 | | | $ | — | | | $ | 34,422 | | | $ | — | | | Residential collateralized mortgage obligations | | 162,275 | | | — | | | 162,275 | | | — | | | Municipal securities - tax exempt | | 5,809 | | | — | | | 5,809 | | | — | | | Equity Investments: | | | | | | | | | | Mutual fund - CRA qualified | | 3,777 | | | 3,777 | | | — | | | — | | | Derivative assets: | | | | | | | | | | Interest rate products | | 142 | | | — | | | 142 | | | — | | Liabilities: | | | | | | | | | | Derivative liabilities: | | | | | | | | | | Interest rate products | | 339 | | | — | | | 339 | | | — | | | | | | | | | | | | December 31, 2025 | | | | | | | | | Assets: | | | | | | | | | | AFS debt securities: | | | | | | | | | | U.S. Government agencies or sponsored agency securities: | | | | | | | | | | Residential mortgage-backed securities | | $ | 32,694 | | | $ | — | | | $ | 32,694 | | | $ | — | | | Residential collateralized mortgage obligations | | 154,463 | | | — | | | 154,463 | | | — | | | Municipal securities - tax exempt | | 5,628 | | | — | | | 5,628 | | | — | | | Equity Investments: | | | | | | | | | | Mutual fund - CRA qualified | | 3,757 | | | 3,757 | | | — | | | — | | | | | | | | | | | | | | | | | | | | Liabilities: | | | | | | | | | | Derivative liabilities: | | | | | | | | | | Interest rate products | | 888 | | | — | | | 888 | | | — | | |
|
| Schedule of Fair Value Hierarchy and Fair Value of Assets that Were Still Held and Had Fair Value Adjustments Measured On a Nonrecurring Basis |
The following table presents the fair value hierarchy and fair value of assets that were still held and had fair value adjustments measured on a nonrecurring basis as of June 30, 2026 and December 31, 2025: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value Measure on a Nonrecurring Basis | | ($ in thousands) | | Total Fair Value | | Quoted Prices in Active Markets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Significant Unobservable Inputs (Level 3) | | June 30, 2026 | | | | | | | | | | Collateral-dependent loans: | | | | | | | | | | CRE | | $ | 1,084 | | | $ | — | | | $ | — | | | $ | 1,084 | | | SBA—real estate | | 4,434 | | | — | | | — | | | 4,434 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total | | $ | 5,518 | | | $ | — | | | $ | — | | | $ | 5,518 | | | | | | | | | | | | December 31, 2025 | | | | | | | | | | Collateral-dependent loans: | | | | | | | | | | CRE | | $ | 450 | | | $ | — | | | $ | — | | | $ | 450 | | | SBA—real estate | | 3,330 | | | — | | | — | | | 3,330 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total | | $ | 3,780 | | | $ | — | | | $ | — | | | $ | 3,780 | | | Total | | | | | | | | |
|
| Schedule of Information about Significant Unobservable Inputs Utilized in Company's Nonrecurring Level 3 Fair Value Measurements |
The following table presents information about significant unobservable inputs utilized in the Company’s nonrecurring Level 3 fair value measurements as of June 30, 2026 and December 31, 2025: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ($ in thousands) | | Fair Value Measurements (Level 3) | | Valuation Techniques | | Unobservable Inputs | | Input Value | | | | June 30, 2026 | | | | | | | | | | | | Collateral-dependent loans: | | $ | 4,301 | | | Fair value of collateral | | Selling cost | | 8.5% | | | | | 1,217 | | | Fair value of collateral | | Selling cost and Discount | | 28.5% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | December 31, 2025 | | | | | | | | | | | | Collateral-dependent loans: | | $ | 2,383 | | | Fair value of collateral | | Selling cost | | 8.5% | | | | | 1,397 | | | Fair value of collateral | | Selling cost and Discount | | 28.5% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| Schedule of Carrying Amounts and Estimated Fair Values of Financial Instruments Not Carried at Fair Value |
The carrying amounts and estimated fair values of financial instruments that are not carried at fair value on a recurring basis as of June 30, 2026 and December 31, 2025 are as follows. These financial assets and liabilities are measured at amortized cost basis on the Company’s Consolidated Balance Sheets: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | June 30, 2026 | | ($ in thousands) | | Carrying Amount | | Level 1 | | Level 2 | | Level 3 | | Fair Value | | Financial assets: | | | | | | | | | | | | Cash and cash equivalents | | $ | 175,051 | | | $ | 175,051 | | | $ | — | | | $ | — | | | $ | 175,051 | | | Loans held for sale | | 21,305 | | | — | | | 23,054 | | | — | | | 23,054 | | | Net loans | | 2,230,961 | | | — | | | — | | | 2,255,450 | | | 2,255,450 | | | Accrued interest receivable, net | | 10,172 | | | 89 | | | 861 | | | 9,222 | | | 10,172 | | | Other investments: | | | | | | | | | | | | FHLB and PCBB stock | | 14,938 | | | N/A | | N/A | | N/A | | N/A | | Time deposits placed | | 109 | | | — | | | 109 | | | — | | | 109 | | | | | | | | | | | | | | Financial liabilities: | | | | | | | | | | | | Deposits | | 2,368,339 | | | — | | | 2,368,423 | | | — | | | 2,368,423 | | | FHLB advances | | 75,000 | | | — | | | 80,443 | | | — | | | 80,443 | | | Subordinated note, net | | 24,629 | | | — | | | 26,416 | | | — | | | 26,416 | | | Accrued interest payable | | 15,949 | | | — | | | 15,949 | | | — | | | 15,949 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | December 31, 2025 | | ($ in thousands) | | Carrying Amount | | Level 1 | | Level 2 | | Level 3 | | Fair Value | | Financial assets: | | | | | | | | | | | | Cash and cash equivalents | | $ | 167,311 | | | $ | 167,311 | | | $ | — | | | $ | — | | | $ | 167,311 | | | Loans held for sale | | 11,443 | | | — | | | 12,267 | | | — | | | 12,267 | | | Net loans | | 2,165,694 | | | — | | | — | | | 2,243,772 | | | 2,243,772 | | | Accrued interest receivable, net | | 10,482 | | | 7 | | | 1,708 | | | 8,767 | | | 10,482 | | | Other investments: | | | | | | | | | | | | FHLB and PCBB stock | | 13,346 | | | N/A | | N/A | | N/A | | N/A | | Time deposits placed | | 105 | | | — | | | 105 | | | — | | | 105 | | | | | | | | | | | | | | Financial liabilities: | | | | | | | | | | | | Deposits | | 2,280,547 | | | — | | | 2,283,339 | | | — | | | 2,283,339 | | | FHLB advances | | 75,000 | | | — | | | 75,792 | | | — | | | 75,792 | | | Subordinated note, net | | 24,586 | | | — | | | 24,845 | | | — | | | 24,845 | | | Accrued interest payable | | 14,595 | | | — | | | 14,595 | | | — | | | 14,595 | | |
|